Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Voyager Therapeutics, Inc. | Chief Medical Officer | Common Stock | 158K | $542K | $3.43 | Apr 2, 2025 | Direct |
Voyager Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 126K | Feb 21, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VYGR | Voyager Therapeutics, Inc. | Apr 2, 2025 | 1 | -$34.6K | 4 | Apr 4, 2025 | Chief Medical Officer |
VYGR | Voyager Therapeutics, Inc. | Feb 21, 2025 | 2 | $0 | 4 | Feb 24, 2025 | Chief Medical Officer |
VYGR | Voyager Therapeutics, Inc. | Apr 1, 2024 | 1 | $0 | 4 | Apr 3, 2024 | Chief Medical Officer |
VYGR | Voyager Therapeutics, Inc. | Mar 25, 2024 | 1 | $0 | 4 | Mar 26, 2024 | Chief Medical Officer |
VYGR | Voyager Therapeutics, Inc. | Mar 25, 2024 | 0 | $0 | 3 | Mar 26, 2024 | Chief Medical Officer |